Expression of Nogo-66 Receptor in Human Astrocytoma is Correlated with Tumor Malignancy

Nanxiang Xiong,Jianying Shen,Shuai Li,Junjun Li,Hongyang Zhao
DOI: https://doi.org/10.1007/s11033-011-1015-8
IF: 2.7422
2011-01-01
Molecular Biology Reports
Abstract:Nogo-A is a myelin-associated neuronal growth inhibitory molecule in central nervous system after trauma. However, the physiological functions of Nogo-A in neural development and in healthy oligodendrocytes are largely unknown. In this study, we investigated the expression of Nogo-66 receptor (NgR) protein in 60 cases of human astrocytoma by Western blot RT-PCR and immunohistochemistry. The correlation between the expression of NgR and pathologic grades of astrocyoma was further analyzed. The results showed that the expression of NgR protein and NgR mRNA immunoreactivity score, were decreased markedly with the increasing pathological grades. Double immunostaining results showed that Nogo-A and NgR were colocalized at the interface of astrocytoma cells and extracellular matrix. Our results indicated that NgR may have inhibitory effects on tumor activity and Nogo-A may restrict migration of tumor cells via NgR.
What problem does this paper attempt to address?